kabutan

COSMOS Pharma, Jun-Feb (Cumulative 3Q) Ordinary Profit Increases by 0.3％

Mon Apr 13, 2026 3:30 pm JST Earnings

3349 COSMOS Pharmaceutical Corporation 【J-GAAP】

Earnings Report

COSMOS Pharmaceutical Corporation <3349> [TSE Prime] announced its financial results after the market closed on April 13th (15:30). The consolidated ordinary profit for the cumulative third quarter of the fiscal year ending May 2026 (June 2025 to February 2026) was 33.8 billion yen, a 0.3% increase compared to the same period last year. Progress toward the full-year plan of 43.2 billion yen was 78.4%, also surpassing the five-year average of 75.7%.

Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the March to May period (4Q) is expected to nearly flat at 9.33 billion yen, down 0.6% from the same period last year.

In the most recent three-month period, from December to February (3Q), the consolidated ordinary profit amounted to 11.9 billion yen, a 0.5% decrease compared to the same period last year. The operating profit margin worsened from 4.6% in the same period last year to 4.2%.

Kabutan News

Actual Results

Accumulated Results 3rd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Jun - Feb, 2023 715,311 23,738 25,914 17,357 219.1 75.6 Apr 12, 2024 J-GAAP
Jun - Feb, 2024 752,268 31,627 33,771 22,343 281.9 78.2 Apr 14, 2025 J-GAAP
Jun - Feb, 2025 810,380 32,021 33,865 22,748 287.0 78.4 Apr 13, 2026 J-GAAP
YoY +7.7% +1.2% +0.3% +1.8% +1.8%

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec - May, 2024 505,454 20,060 21,383 16,550 208.8 37.50 Jul 11, 2025 J-GAAP
Dec - May, 2025 Guidance 519,825 19,824 21,266 16,352 206.3 37.50 Jan 13, 2026 J-GAAP
YoY +2.8% -1.2% -0.5% -1.2% -1.2%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
May, 2024 964,989 31,501 34,299 24,454 308.6 60 Jul 12, 2024 J-GAAP
May, 2025 1,011,390 40,404 43,160 30,978 390.9 70 Jul 11, 2025 J-GAAP
May, 2026 Guidance 1,057,000 40,500 43,200 31,000 391.1 75 Jul 11, 2025 J-GAAP
YoY +4.5% +0.2% +0.1% +0.1% +0.1%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Dec - Feb, 2024 246,332 11,283 11,994 7,915 99.9 4.6 Apr 14, 2025 J-GAAP
Mar - May, 2025 259,122 8,777 9,389 8,635 109.0 3.4 Jul 11, 2025 J-GAAP
Jun - Aug, 2025 272,394 11,645 12,188 8,171 103.1 4.3 Oct 14, 2025 J-GAAP
Sep - Nov, 2025 264,781 9,031 9,746 6,477 81.7 3.4 Jan 13, 2026 J-GAAP
Dec - Feb, 2025 273,205 11,345 11,931 8,100 102.2 4.2 Apr 13, 2026 J-GAAP
YoY +10.9% +0.5% -0.5% +2.3% +2.3%

Related Articles